(Total Views: 591)
Posted On: 05/07/2020 1:40:41 PM
Post# of 154064
UCLA can do the moderate trial very quickly. But the idea is to do a multi-site trial, so that is impossible. As far as I know Novant is only doing the phase 2 moderate trial. Palmtree starts next week.
Looking at the recent update on the severely ill patient phase 2b/3 trial it was interesting to see that the number of recruiting sites was not increased. Only Montefiore still mentioned.
Looks like Dr. Yang (UCLA) prefers EIND above the severe trial?
gf
Looking at the recent update on the severely ill patient phase 2b/3 trial it was interesting to see that the number of recruiting sites was not increased. Only Montefiore still mentioned.
Looks like Dr. Yang (UCLA) prefers EIND above the severe trial?
gf
(0)
(0)
